Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Effects of Quercetin on Cardiometabolic Health

Official title: Effects of Quercetin Supplementation on Cardiometabolic Parameters

Run by University of Central Lancashire · NCT06230861 · Data updated 2026-11-12

This study tests if taking Quercetin can help improve heart and metabolic health in healthy adults aged 18 to 65 compared to a placebo.

More Cardiometabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Central Lancashire
Academic / other
Locations1 site (Preston, Lancashire)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedAugust 1, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 10, 2026
Trial IDNCT06230861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults aged 18 to 65 with a BMI under 30 who do not smoke.

Probably not a fit

Patients with diabetes, uncontrolled hypertension, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the potential benefits of Quercetin, a natural compound, on improving cardiometabolic outcomes in healthy adults. Participants aged 18 to 65 will be randomly assigned to receive either Quercetin or a placebo, allowing researchers to assess its effects on cardiovascular health and metabolic function. The study aims to provide a safer dietary intervention compared to traditional pharmacological treatments for cardiometabolic syndrome. By focusing on a placebo-controlled design, the research seeks to establish a clearer understanding of Quercetin's efficacy.

Why it matters

Potential benefit: If successful, this study could offer a natural dietary intervention to improve cardiometabolic health and reduce the risk of related diseases.

How similar studies have gone: While dietary interventions for cardiometabolic health are common, this specific approach using Quercetin in a placebo-controlled setting is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy
* Between 18 \& 65 years
* BMI \< 30
* Able to give informed consent

Exclusion Criteria:

* Pregnancy
* Diabetes or any other metabolic/ uncontrolled hypertensive conditions
* Food allergies to quercetin
* Habitual consumption of quercetin
* Not regularly taking medication or antioxidant supplements

Where it's running

  • University of Central Lancashire
    Preston, Lancashire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.